-
1
-
-
79952007082
-
Definition of organ involvement and response to treatment in AL amyloidosis: An updated consensus opinion
-
Gertz MA, Merlini G. Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion. Amyloid 2010;17:48-9.
-
(2010)
Amyloid
, vol.17
, pp. 48-49
-
-
Gertz, M.A.1
Merlini, G.2
-
2
-
-
33646408531
-
Monoclonal gammopathy of undetermined significance,Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: Diagnosis and treatment
-
Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance,Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc 2006;81:693-703.
-
(2006)
Mayo Clin Proc
, vol.81
, pp. 693-703
-
-
Rajkumar, S.V.1
Dispenzieri, A.2
Kyle, R.A.3
-
3
-
-
25444434458
-
Diagnosis and management of the cardiac amyloidoses
-
Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005; 112:2047-60.
-
(2005)
Circulation
, vol.112
, pp. 2047-2060
-
-
Falk, R.H.1
-
4
-
-
0034153950
-
Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement
-
Grogan M, Gertz MA, Kyle RA, Tajik AJ. Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2000;85:664-5.
-
(2000)
Am J Cardiol
, vol.85
, pp. 664-665
-
-
Grogan, M.1
Gertz, M.A.2
Kyle, R.A.3
Tajik, A.J.4
-
6
-
-
35848949074
-
The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
-
American Heart Association; American College of Cardiology; European Society of Cardiology; Heart Failure Society of America; Heart Failure Association of the European Society of Cardiology
-
Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U et al.; American Heart Association; American College of Cardiology; European Society of Cardiology; Heart Failure Society of America; Heart Failure Association of the European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216-33.
-
(2007)
Circulation
, vol.116
, pp. 2216-2233
-
-
Cooper, L.T.1
Baughman, K.L.2
Feldman, A.M.3
Frustaci, A.4
Jessup, M.5
Kuhl, U.6
-
7
-
-
0842330668
-
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis
-
Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43:410-5.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 410-415
-
-
Rahman, J.E.1
Helou, E.F.2
Gelzer-Bell, R.3
Thompson, R.E.4
Kuo, C.5
Rodriguez, E.R.6
-
8
-
-
0026585195
-
Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis
-
Simons M, Isner JM. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 1992;69:425-7.
-
(1992)
Am J Cardiol
, vol.69
, pp. 425-427
-
-
Simons, M.1
Isner, J.M.2
-
9
-
-
0019932878
-
Amyloid cardiomyopathy: Characterization by a distinctive voltage/mass relation
-
Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol 1982;49:9-13.
-
(1982)
Am J Cardiol
, vol.49
, pp. 9-13
-
-
Carroll, J.D.1
Gaasch, W.H.2
McAdam, K.P.3
-
10
-
-
84904766269
-
Cardiac amyloidosis without increased left ventricular wall thickness
-
Lee GY, Kim K, Choi JO, Kim SJ, Kim JS, Choe YH et al. Cardiac amyloidosis without increased left ventricular wall thickness. Mayo Clin Proc 2014;89:781-9.
-
(2014)
Mayo Clin Proc
, vol.89
, pp. 781-789
-
-
Lee, G.Y.1
Kim, K.2
Choi, J.O.3
Kim, S.J.4
Kim, J.S.5
Choe, Y.H.6
-
11
-
-
75949091211
-
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis
-
Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010;3:155-64.
-
(2010)
JACC Cardiovasc Imaging
, vol.3
, pp. 155-164
-
-
Syed, I.S.1
Glockner, J.F.2
Feng, D.3
Araoz, P.A.4
Martinez, M.W.5
Edwards, W.D.6
-
12
-
-
84897460859
-
Advanced cardiac amyloidosis associated with normal interventricular septal thickness: An uncommon presentation of infiltrative cardiomyopathy
-
Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A et al. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr 2014;27:440-7.
-
(2014)
J Am Soc Echocardiogr
, vol.27
, pp. 440-447
-
-
Suresh, R.1
Grogan, M.2
Maleszewski, J.J.3
Pellikka, P.A.4
Hanna, M.5
Dispenzieri, A.6
-
13
-
-
84878406657
-
Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis
-
Mussinelli R, Salinaro F, Alogna A, Boldrini M, Raimondi A, Musca F et al. Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis. Ann Noninvasive Electrocardiol 2013;18:271-80.
-
(2013)
Ann Noninvasive Electrocardiol
, vol.18
, pp. 271-280
-
-
Mussinelli, R.1
Salinaro, F.2
Alogna, A.3
Boldrini, M.4
Raimondi, A.5
Musca, F.6
-
14
-
-
0025978147
-
Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis
-
Klein AL, Hatle LK, Taliercio CP, Oh JK, Kyle RA, Gertz MA et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. Circulation 1991;83:808-16.
-
(1991)
Circulation
, vol.83
, pp. 808-816
-
-
Klein, A.L.1
Hatle, L.K.2
Taliercio, C.P.3
Oh, J.K.4
Kyle, R.A.5
Gertz, M.A.6
-
15
-
-
0030796414
-
Right ventricular dilation in primary amyloidosis: An independent predictor of survival
-
Patel AR, Dubrey SW, Mendes LA, Skinner M, Cupples A, Falk RH et al. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol 1997;80:486-92.
-
(1997)
Am J Cardiol
, vol.80
, pp. 486-492
-
-
Patel, A.R.1
Dubrey, S.W.2
Mendes, L.A.3
Skinner, M.4
Cupples, A.5
Falk, R.H.6
-
16
-
-
34247860739
-
Noninvasive predictors of survival in cardiac amyloidosis
-
Kristen AV, Perz JB, Schonland SO, Hegenbart U, Schnabel PA, Kristen JH et al. Noninvasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007;9:617-24.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 617-624
-
-
Kristen, A.V.1
Perz, J.B.2
Schonland, S.O.3
Hegenbart, U.4
Schnabel, P.A.5
Kristen, J.H.6
-
17
-
-
0030246847
-
Doppler index combining systolic and diastolic myocardial performance clinical value in cardiac amyloidosis
-
Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996;28:658-64.
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 658-664
-
-
Tei, C.1
Dujardin, K.S.2
Hodge, D.O.3
Kyle, R.A.4
Tajik, A.J.5
Seward, J.B.6
-
18
-
-
78149291059
-
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis
-
Palladini G, Barassi A, Klersy C, Pacciolla R, Milani P, Sarais G et al. The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood 2010;116:3426-30.
-
(2010)
Blood
, vol.116
, pp. 3426-3430
-
-
Palladini, G.1
Barassi, A.2
Klersy, C.3
Pacciolla, R.4
Milani, P.5
Sarais, G.6
-
19
-
-
71749086300
-
Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis
-
Austin BA, Tang WH, Rodriguez ER, Tan C, Flamm SD, Taylor DO et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2009;2:1369-77.
-
(2009)
JACC Cardiovasc Imaging
, vol.2
, pp. 1369-1377
-
-
Austin, B.A.1
Tang, W.H.2
Rodriguez, E.R.3
Tan, C.4
Flamm, S.D.5
Taylor, D.O.6
-
20
-
-
19944430773
-
Cardiovascular magnetic resonance in cardiac amyloidosis
-
Maceira AM, Joshi J, Prasad SK, Roughton M, Pennell DJ. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-93.
-
(2005)
Circulation
, vol.111
, pp. 186-193
-
-
Maceira, A.M.1
Joshi, J.2
Prasad, S.K.3
Roughton, M.4
Pennell, D.J.5
-
22
-
-
39849086657
-
Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: Noninvasive imaging compared to endomyocardial biopsy
-
Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Gruelich S et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51:1022-30.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1022-1030
-
-
Vogelsberg, H.1
Mahrholdt, H.2
Deluigi, C.C.3
Yilmaz, A.4
Kispert, E.M.5
Gruelich, S.6
-
23
-
-
59049105664
-
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light chain cardiac amyloidosis
-
Ruberg FL, Appelbaum E, Davidoff R, Ozonoff A, Kissinger KV, Harrigan C et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light chain cardiac amyloidosis. Am J Cardiol 2009;103:544-9.
-
(2009)
Am J Cardiol
, vol.103
, pp. 544-549
-
-
Ruberg, F.L.1
Appelbaum, E.2
Davidoff, R.3
Ozonoff, A.4
Kissinger, K.V.5
Harrigan, C.6
-
24
-
-
58749099485
-
Cardiovascularmagnetic resonance and prognosis in cardiac amyloidosis
-
Maceira AM, Prasad SK, Hawkins PN, RoughtonM, Pennell DJ. Cardiovascularmagnetic resonance and prognosis in cardiac amyloidosis. J CardiovascMagn Reson 2008;10:54.
-
(2008)
J CardiovascMagn Reson
, vol.10
, pp. 54
-
-
Maceira, A.M.1
Prasad, S.K.2
Hawkins, P.N.3
Roughton, M.4
Pennell, D.J.5
-
25
-
-
2942716986
-
Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology
-
Mahrholdt H, Goedecke E, Wagner A, Yilmaz A, Kispert EM, Greulich S et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
-
(2004)
Circulation
, vol.109
, pp. 1250-1258
-
-
Mahrholdt, H.1
Goedecke, E.2
Wagner, A.3
Yilmaz, A.4
Kispert, E.M.5
Greulich, S.6
-
26
-
-
0038518441
-
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis
-
Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003;107:2440-5.
-
(2003)
Circulation
, vol.107
, pp. 2440-2445
-
-
Palladini, G.1
Campana, C.2
Klersy, C.3
Balduini, A.4
Vadacca, G.5
Perfetti, V.6
-
27
-
-
84893860072
-
CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis
-
White JA, Kim HW, Shah D, Fine N, Kim KY,Wendell DC et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging 2014;7:143-56
-
(2014)
JACC Cardiovasc Imaging
, vol.7
, pp. 143-156
-
-
White, J.A.1
Kim, H.W.2
Shah, D.3
Fine, N.4
Kim, K.Y.5
Wendell, D.C.6
-
28
-
-
84945460974
-
Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis
-
Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2015;132:1570-9.
-
(2015)
Circulation
, vol.132
, pp. 1570-1579
-
-
Fontana, M.1
Pica, S.2
Reant, P.3
Abdel-Gadir, A.4
Treibel, T.A.5
Banypersad, S.M.6
|